by John Conrad | Jun 10, 2024 | NewsBrief
In a time of economic uncertainty and inflation, the STEM job market remains resilient. Despite the wave of layoffs in the tech sector in 2023 and 2024, the demand for STEM and R&D talent in the U.S. remains strong overall. A recent analysis of over 5,000 job...
by John Conrad | Jun 7, 2024 | NewsBrief
AbbVie’s strategic acquisition of ImmunoGen for $10.1 billion in November 2023 is already showing promising results. The deal, which included the antibody-drug conjugate (ADC) Elahere, has yielded positive outcomes in a recent Phase 2 study. According to...
by John Conrad | Jun 7, 2024 | NewsBrief
Illinois has long been recognized as a center of innovation and growth, particularly in the bio manufacturing industry. The state’s commitment to fostering a supportive business environment, coupled with its highly skilled workforce and world-class research...
by John Conrad | Jun 6, 2024 | NewsBrief
The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
by John Conrad | Jun 5, 2024 | NewsBrief
Abbott Laboratories has received clearance from the U.S. Food and Drug Administration (FDA) to sell its Lingo glucose monitor over the counter, without a prescription. The clearance, which came on May 29 according to the FDA’s website, positions Abbott to...
by John Conrad | Jun 4, 2024 | NewsBrief
Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered in Taiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory located in the suburbs of Chicago. The strategic move, finalized on June 3, 2024, aims to...
